Crohn’s Disease Therapeutics Market to Reach US$ 18,435.00 Million by 2031 at 4.1% CAGR
Crohn’s disease is a chronic inflammatory bowel disorder that requires long term treatment and continuous disease management. The growing burden of gastrointestinal disorders, rising awareness, and improvements in diagnostic capabilities are encouraging the adoption of advanced therapeutic approaches across healthcare … Read more